[图书][B] Proteasomes: the world of regulatory proteolysis

W Hilt - 2000 - taylorfrancis.com
This book highlights proteasome structures and how they are related to different aspects of
proteasome function. Moreover, the book reports on the functional roles these highly …

Proteasome inhibitors: an expanding army attacking a unique target

AF Kisselev, WA van der Linden, HS Overkleeft - Chemistry & biology, 2012 - cell.com
Proteasomes are large, multisubunit proteolytic complexes presenting multiple targets for
therapeutic intervention. The 26S proteasome consists of a 20S proteolytic core and one or …

Endoplasmic reticulum stress compromises the ubiquitin–proteasome system

V Menendez-Benito, LGGC Verhoef… - Human molecular …, 2005 - academic.oup.com
The presence of endoplasmic reticulum (ER) stress and impaired ubiquitin–proteasome
system (UPS) activity has been independently implicated in the pathophysiology of …

Inhibition of NGLY1 inactivates the transcription factor Nrf1 and potentiates proteasome inhibitor cytotoxicity

FM Tomlin, UIM Gerling-Driessen, YC Liu… - ACS central …, 2017 - ACS Publications
Proteasome inhibitors are used to treat blood cancers such as multiple myeloma (MM) and
mantle cell lymphoma. The efficacy of these drugs is frequently undermined by acquired …

Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy

M Frezza, S Schmitt, Q Ping Dou - Current topics in medicinal …, 2011 - ingentaconnect.com
Selective degradation of proteins by the ubiquitin-proteasome pathway is a critical
determinant for maintaining cellular homeostasis. Most intracellular proteins are degraded …

Proteasome regulation by ADP-ribosylation

PF Cho-Park, H Steller - Cell, 2013 - cell.com
Protein degradation by the ubiquitin-proteasome system is central to cell homeostasis and
survival. Defects in this process are associated with diseases such as cancer and …

Positioning of proteasome inhibitors in therapy of solid malignancies

MSF Roeten, J Cloos, G Jansen - Cancer chemotherapy and …, 2018 - Springer
Targeting of the protein degradation pathway, in particular, the ubiquitin-proteasome system,
has emerged as an attractive novel cancer chemotherapeutic modality. Although …

Immunoproteasome in cancer and neuropathologies: a new therapeutic target?

E Bellavista, F Andreoli… - Current …, 2013 - ingentaconnect.com
Immunoproteasome is an emerging biological target that constitutes a key element not only
in antigen presentation but also in T cell and cytokine regulation as well as cellular …

Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part I: targeting p53, Mdm2, GADD153/CHOP …

DC Hiss, GA Gabriels - Expert opinion on drug discovery, 2009 - Taylor & Francis
Background: In eukaryotes, endoplasmic reticulum stress (ERS) and the unfolded protein
response (UPR) are coordinately regulated to maintain steady-state levels and activities of …

Harnessing proteasome dynamics and allostery in drug design

M Gaczynska, PA Osmulski - Antioxidants & redox signaling, 2014 - liebertpub.com
Significance: The proteasome is the essential protease that is responsible for regulated
cleavage of the bulk of intracellular proteins. Its central role in cellular physiology has been …